End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.26 CNY | +2.69% | +3.86% | -9.25% |
Apr. 15 | Grifols Plans to Appoint Independent Directors Only to Audit, Compensation Committees | MT |
Apr. 10 | Grifols to refinance debt due in 2025 via sales of notes, Shanghai RAAS stake | RE |
Chart calendar Shanghai RAAS Blood Products Co., Ltd.
Upcoming events on Shanghai RAAS Blood Products Co., Ltd.
Past events on Shanghai RAAS Blood Products Co., Ltd.
2024-04-11 | Q4 2023 Earnings Release |
2024-02-07 01:00 am | Extraordinary Shareholders Meeting |
2023-12-11 01:00 am | Extraordinary Shareholders Meeting |
2023-10-24 | Q3 2023 Earnings Release |
2023-08-29 | Q2 2023 Earnings Release |
2023-08-16 02:00 am | Extraordinary Shareholders Meeting |
2023-05-22 01:00 am | Annual General Meeting |
2023-04-27 | Q1 2023 Earnings Release |
2023-04-24 | Q4 2022 Earnings Release |
2022-12-29 12:00 am | Extraordinary Shareholders Meeting |
2022-10-28 | Q3 2022 Earnings Release |
2022-08-29 | Interim 2022 Earnings Release |
2022-06-14 01:00 am | Annual General Meeting |
2022-04-29 | Q1 2022 Earnings Release |
2022-04-27 | FY 2021 Earnings Release |
2022-02-14 12:00 am | Extraordinary Shareholders Meeting |
2021-10-27 | Q3 2021 Earnings Release |
2021-08-19 | Interim 2021 Earnings Release |
2021-07-30 01:00 am | Extraordinary Shareholders Meeting |
2021-05-20 01:00 am | Annual General Meeting |
Past dividends on Shanghai RAAS Blood Products Co., Ltd.
2023-06-12 | Annual 0.03 CNY |
2022-07-06 | Annual 0.028 CNY |
2021-07-01 | Annual 0.025 CNY |
2020-07-14 | Annual 0.01 CNY |
2018-06-27 | Annual 0.017 CNY |
2017-06-19 | Annual 0.03 CNY |
2016-05-26 | Annual 0.05 CNY |
2015-04-08 | Annual 0.1 CNY |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 7 799 |
EBITDA Million CNY | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 2 572 |
EBIT Million CNY | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 2 712 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 2 703 |
Net income Million CNY | Released Forecast Spread | 1 324 | 1 295 | 1 880 | 2 173 |
EPS CNY | Released Forecast Spread | 0,21 | 0,19 | 0,28 | 0,33 |
Announcement Date | 22/04/21 | 27/04/22 | 24/04/23 | - |
Quarterly results
Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 1 814 | 2 322 | 2 215 | 2 284 | 2 226 | |
Net income Million CNY | Released Forecast Spread | 549 | |||||
EPS CNY | Released Forecast Spread | 0,08 | 0,05 | 0,12 | 0,09 | 0,11 | 0,06 |
Announcement Date | 24/10/23 | - | - | - | - | - |
Past sector events for Shanghai RAAS Blood Products Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002252 Stock
- Calendar Shanghai RAAS Blood Products Co., Ltd.